News from merck kgaa A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 05, 2019, 07:21 ET Merck KGaA, Darmstadt, Germany and GSK Announce Global Alliance to Jointly Develop and Commercialize M7824, a Novel Immunotherapy with Potential in Multiple Difficult-to-Treat Cancers

Merck KGaA, Darmstadt, Germany, a leading science and technology company and GSK, a science-led global healthcare company, today announced that the companies have entered into a global strategic...


Jun 12, 2018, 08:00 ET Merck KGaA, Darmstadt, Germany Drives Thought Leadership in Ethical Gene Editing

Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, today announced that The American Journal of Bioethics has accepted a novel publication on...


Jun 04, 2018, 09:50 ET Two-Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO® (avelumab)

/NOT INTENDED FOR UK-BASED MEDIA./ Two-year follow-up data on meaningful durable responses, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic...


Mar 26, 2018, 08:35 ET Merck KGaA, Darmstadt, Germany webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference

Merck KGaA, Darmstadt, Germany (XETRA: MRK.DE, OTC: MKKGY) a leading science and technology company, today announced that their March 22, 2018 presentation is now available for on-demand viewing in...


Mar 20, 2018, 08:35 ET Merck KGaA, Darmstadt, Germany to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 22nd March 2018

Merck KGaA, Darmstadt, Germany (XETRA: MRK, OTC Pink: MKKGY), a leading science and technology company, today announced that it will present at the dbVIC - Deutsche Bank American Depositary Receipt...


Aug 30, 2017, 20:08 ET Merck KGaA, Darmstadt, Germany: Driving Innovation in Cancer Care at ESMO 2017 With New Data in Hard-to-Treat Cancers

DARMSTADT, Germany, Aug. 31, 2017 /CNW/ - Not intended for UK-based media Data to showcase Merck KGaA, Darmstadt, Germany's strong and diverse pipeline ranging from immuno-oncology to DNA damage...


Jul 05, 2017, 04:50 ET Merck KGaA, Darmstadt, Germany Awards €1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation (GFI)

Two projects are awarded funds to advance the fertility field Professor Lunenfeld honored with Merck KGaA, Darmstadt, Germany Lifetime Achievement Award The company is committed to driving innovation ...


Mar 02, 2017, 02:56 ET NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC

DARMSTADT, Germany, March 2, 2017 /CNW/ - Not intended for UK- or US-based media More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX NICE's...


Sep 28, 2016, 04:23 ET Merck KGaA, Darmstadt, Germany to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

DARMSTADT, Germany, Sept. 28, 2016 /CNW/ - Not intended for UK-based media ESMO Abstract # Avelumab: 777PD, 7775PD, 1154P, 842TiP, 844TiP; Erbitux: 527P, 491P, 967P, 994P; Tepotinib: 1257P, 1287TiP,...


Sep 14, 2016, 08:00 ET Merck KGaA, Darmstadt, Germany, Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes

Merck KGaA, Darmstadt, Germany, a leading science and technology company, has joined the DiViNe project, a European consortium of six companies to address the biggest challenges facing the...


Jun 30, 2016, 03:15 ET Merck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance

New partners are joining founding members Merck KGaA, Darmstadt, Germany, Illumina and Genea to support standardization of processes in assisted reproductive treatment laboratories Update on the...


Apr 25, 2016, 03:03 ET Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone

DARMSTADT, Germany, April 25, 2016 /CNW/ - Not intended for UK- or US-based media Chinese pivotal Phase III study meets its primary endpoint of increased progression-free survival in first-line...


Apr 11, 2016, 03:15 ET Merck Makes Pioneering Technologies Gavi, Geri and Gems Available to Fertility Clinics

/Not intended for U.S. based media/ Merck obtains CE mark certification for consumables of Gavi™ and Geri™ as well as for the embryo culture media suite Gems™ Geri™ now incorporating innovative...


Feb 22, 2016, 11:30 ET Merck Puts Spotlight on Women's Health and Well-being

Merck's Consumer Health business takes the lead in addressing health and well-being challenges of women around the world Experts worldwide join a debate on how best to close the gap between the...


Feb 03, 2016, 03:17 ET Merck Set to Launch New Version of Fertility Pens

DARMSTADT, Germany, Feb. 3, 2016 /CNW/ - Not intended for UK and U.S. based media The Fertility Leader Merck receives market authorization from EMA for its advanced GONAL-f® prefilled pen for...


Oct 22, 2015, 08:00 ET EMD Millipore to Provide Provantage® End-to-End Solution for Development and Manufacture of Biosimilars under Strategic Alliance with Turgut Ilac

EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today announced the Company has entered into a strategic alliance with Turgut Ilac, a leading biosimilars company based...


Oct 01, 2015, 03:56 ET Merck Agrees to Return Kuvan® Rights to BioMarin Pharmaceutical to Strengthen Focus on Core Business

DARMSTADT, Germany, Oct. 1, 2015 /CNW/ - Agreement with BioMarin, a leading company in the treatment of genetic and rare diseases, also includes returning option to develop and commercialize Peg-Pal...


Jun 23, 2015, 11:11 ET Merck KGaA, Darmstadt, Germany, Launches "More than a Mother" Campaign Aiming to Reduce Social Suffering of Infertile Women in Africa

"More than a Mother" will first be implemented in Kenya in partnership with University of Nairobi and Kenya Women Parliamentary Association and progressively rolled out in further African countries...


Sep 18, 2014, 11:39 ET Merck KGaA Strengthens Executive Board

Stefan Oschmann appointed Deputy CEO and Vice Chairman of the Executive Board Belén Garijo appointed new member of the Executive Board Changes effective from January 1, 2015 DARMSTADT, Germany, Sept. ...


Sep 12, 2014, 10:54 ET Merck KGaA Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer

DARMSTADT, Germany, Sept. 12, 2014 /CNW/ - Merck KGaA, Darmstadt, Germany, announced today that its biopharmaceutical division will discontinue the clinical development program of its investigational ...